Abstract:<p>The presence of pharmaceutical residues in aquatic ecosystems is a worldwide problem that may pose serious threats and challenges to the environment, especially to the safety of aquatic biota. In the present study, we investigated the effects of 14 environmentally relevant pharmaceutical compounds on individual and collective-related behaviours in juvenile zebrafish (<em>Danio rerio</em>) for 21 days. The tested concentrations of the compounds spanned three orders of magnitude. This study also compared the potential risks of these compounds in Chinese surface waters based on the data on their toxic effects or only on behavioural effects. In the case of individual behaviours, most antidepressants, but not anti-inflammatory agents or blood lipid-lowering agents, decreased fish locomotor activity (LMA) and individual social activity (IDS); however, all three classes of compounds induced significant disruptions in the light/dark transition locomotor response (LMR-L/D) performance, even at lower treatment levels (0.1–1 μg/L). Furthermore, collective behaviour (CLB) analysis suggested that most of the compounds significantly altered the group sociability of fish and frequently occurred at environmentally relevant concentrations. Finally, a risk assessment suggested that the presence of ibuprofen, fluoxetine, and venlafaxine in the surface waters of China poses a relatively high risk to fish, regardless of the risk ranking based on the data of the toxic or behavioural effects.</p>

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the impact of 14 common drugs on the aquatic environment, especially on the behavior of zebrafish. Specifically, the study focused on the effects of these drugs on the individual and group behaviors of zebrafish, as well as their potential risks in China's surface water. Through 21 - day experimental exposure, the researchers explored the specific effects of different concentrations of anti - inflammatory drugs, lipid - lowering drugs and antidepressants on the locomotor activity, light - dark transition response, individual social behavior and group behavior of zebrafish. In addition, a risk assessment was also carried out to determine the relative risks of these drugs in the environment, especially the safety for fish. ### Main problems 1. **Effects of drugs on zebrafish behavior**: - Antidepressants led to a significant decrease in the movement speed of zebrafish, especially in the concentration range from 10 μg/L to 1000 μg/L. - The impact of drug exposure on the light - dark transition response of zebrafish, especially at low concentrations (0.1 μg/L and 1 μg/L). - Antidepressants significantly reduced the individual social behavior of zebrafish, especially in the concentration groups of 10 μg/L, 100 μg/L and 1000 μg/L. - The impact of drugs on the group behavior of zebrafish, including changes in group cohesion. 2. **Risk assessment**: - Evaluate the potential risks of these drugs in China's surface water through the relative risk value (RRm) and the preventive risk ratio (pRR). - Special attention was paid to the risks of ibuprofen, fluoxetine and venlafaxine. The presence of these drugs in surface water may pose a relatively high risk to fish. ### Research methods - **Selection of chemicals**: 14 drugs were selected, including 3 anti - inflammatory drugs, 3 lipid - lowering drugs and 8 antidepressants. - **Experimental design**: Juvenile zebrafish were used for a 21 - day drug exposure experiment, and multiple behavioral indicators were tested, including locomotor activity, light - dark transition response, individual social behavior and group behavior. - **Data analysis**: Data were processed and analyzed by statistical analysis software (such as OriginPro 2020 and IBM SPSS v25) to evaluate the effects of drugs on zebrafish behavior. ### Conclusions - **Antidepressants**: Have the greatest impact on the behavior of zebrafish, especially on locomotor activity and social behavior. - **Anti - inflammatory drugs and lipid - lowering drugs**: Also showed certain behavioral effects at some high concentrations, but generally not as significant as antidepressants. - **Risk assessment**: Ibuprofen, fluoxetine and venlafaxine have relatively high potential risks in China's surface water and need further attention and management. Through these studies, the paper aims to raise awareness of the potential threats of drug residues to the aquatic ecosystem and provide a scientific basis for formulating corresponding environmental protection measures.

Risks to aquatic environments posed by 14 pharmaceuticals as illustrated by their effects on zebrafish behaviour

Behavioral Profile Alterations in Zebrafish Larvae Exposed to Environmentally Relevant Concentrations of Eight Priority Pharmaceuticals

Environmental Occurrence and Predicted Pharmacological Risk to Freshwater Fish of over 200 Neuroactive Pharmaceuticals in Widespread Use

Pharmaceutical Compounds in Aquatic Environment in China: Locally Screening and Environmental Risk Assessment

Predicting the potential risks posed by antidepressants as emerging contaminants in fish based on network pharmacological analysis

Antidepressants As Emerging Contaminants: Occurrence in Wastewater Treatment Plants and Surface Waters in Hangzhou, China.

Pharmaceuticals in two watersheds in Eastern China and their ecological risks.

Residues of Cardiovascular and Lipid-Lowering Drugs Pose a Risk to the Aquatic Ecosystem despite a High Wastewater Treatment Ratio in the Megacity Shanghai, China

The Relative Risk and Its Distribution of Endocrine Disrupting Chemicals, Pharmaceuticals and Personal Care Products to Freshwater Organisms in the Bohai Rim, China.

Low doses and lifecycle exposure of waterborne antidepressants in zebrafish model: A survey on sperm traits, reproductive behaviours, and transcriptome responses

Multimarker Responses of Zebrafish to the Effect of Ibuprofen and Gemfibrozil in Environmentally Relevant Concentrations

The potential for adverse effects in fish exposed to antidepressants in the aquatic environment

Medicating the coast in a metropolitan city: Enantiomeric profiles and joint probabilistic risk assessment of antidepressants and antihistamines

Waterborne pharmaceutical uptake and toxicity is modified by pH and dissolved organic carbon in zebrafish

Cardiovascular drugs and lipid regulating agents in surface waters at global scale: Occurrence, ecotoxicity and risk assessment

Linking Pharmaceutical Residues to Dissolved Organic Matter and Aquatic Bacterial Communities in a Highly Urbanized Bay.

Occurrence and a Screening‐level Risk Assessment of Human Pharmaceuticals in the Pearl River System, South China

Source Apportionment, Hydrodynamic Influence, and Environmental Stress of Pharmaceuticals in a Microtidal Estuary with Multiple Outlets in South China

Simultaneous Occurrence of Psychotropic Pharmaceuticals in Surface Water of the Megacity Shanghai and Implication for Their Ecotoxicological Risks

The neurobehavioral impacts of typical antibiotics toward zebrafish larvae

Toxic effects of four cardiovascular drugs on the development and epigenetics of zebrafish (Danio rerio)